Financial Results for the Third Quarter of FY2017
(Apr. 1 to Dec. 31)

from the beginning

Financial Results for the Third Quarter of FY2017

• Overview of the Financial Results for the 1H of FY2017

• Analysis of Factors Causing Changes in Operating Income

• Sales per Medical Institution Types (Japan)(non-consolidated)

• Sales by Listed Year of Drugs (Japan)

• Comparison of Sales Volume (Japan)

• Sales breakdown by Therapeutic category (North America)

• North America Business Pipeline

• FY2017 Earnings Forecasts (IFRS)

Sales by Distribution Channels (Japan)

• Consolidated Financial Highlights-1

• Consolidated Financial Highlights-2

• Consolidated Financial Highlights-3

• Consolidated Financial Date

Disclaimer